<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1012-2966</journal-id>
<journal-title><![CDATA[Gaceta Médica Boliviana]]></journal-title>
<abbrev-journal-title><![CDATA[Gac Med Bol]]></abbrev-journal-title>
<issn>1012-2966</issn>
<publisher>
<publisher-name><![CDATA[Facultad de Medicina de la Universidad Mayor de San Simón]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1012-29662024000100090</article-id>
<article-id pub-id-type="doi">10.47993/gmb.v47i1.800</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Lesión hepática inducida por medicamentos secundaria al consumo de esteroides androgénicos]]></article-title>
<article-title xml:lang="en"><![CDATA[Drug-induced liver injury secondary to androgenic steroid use]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Theran León]]></surname>
<given-names><![CDATA[Juan Sebastian]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Esteban Badillo]]></surname>
<given-names><![CDATA[Laura Yibeth]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Santander medicina familiar ]]></institution>
<addr-line><![CDATA[Bucaramanga ]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2024</year>
</pub-date>
<volume>47</volume>
<numero>1</numero>
<fpage>90</fpage>
<lpage>91</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_arttext&amp;pid=S1012-29662024000100090&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_abstract&amp;pid=S1012-29662024000100090&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_pdf&amp;pid=S1012-29662024000100090&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen El uso de esteroides anabólicos de forma ilícita es un problema en aumento caracterizado por la falta de conocimiento sobre los potenciales efectos secundarios a estos productos. El uso ilegal de los mismos ha llevado a un infra diagnóstico de los eventos adversos, dentro de los más frecuentes se ha encontrado la hepatotoxicidad. Se presenta el caso de un hombre adulto maduro deportista aficionado quien fue hospitalizado por ictericia y enfermedad hepática inducida por medicamentos en relación al uso de esteroides anabólicos en dosis elevadas. La prevención de la lesión hepática inducida por fármacos (DILI) implica educar a los pacientes que toman fármacos hepatotóxicos sobre su uso seguro, enseñar los signos y síntomas asociados con la lesión hepática, así como, la educación a la población vulnerable en prevenir la automedicación o el uso ilegal de estas sustancias.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract The use of anabolic steroids in an illicit way is a growing problem characterized by the lack of knowledge about the potential side effects of these products. Their illegal use has led to under diagnosis of adverse events, among the most frequent of which was hepatotoxicity. We present the case of a mature adult male amateur athlete who was hospitalized for jaundice and drug-induced liver disease in relation to the use of high-dose anabolic steroids. The prevention of drug-induced liver damage (DILI) training the susceptible population about the dangers of self-medication and illegal drug use, as well as educating the vulnerable population to prevent self-medication. or the illegal use of these substances.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[hepatitis]]></kwd>
<kwd lng="es"><![CDATA[esteroides anabólicos]]></kwd>
<kwd lng="es"><![CDATA[hepatotoxicidad]]></kwd>
<kwd lng="es"><![CDATA[DILI]]></kwd>
<kwd lng="en"><![CDATA[hepatitis]]></kwd>
<kwd lng="en"><![CDATA[anabolic steroids]]></kwd>
<kwd lng="en"><![CDATA[hepatotoxicity]]></kwd>
<kwd lng="en"><![CDATA[DILI]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodríguez-Alfaro]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Álvarez-Castillo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Salas Boza]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Esteroides anabólicos repercusiones médicas del uso indiscriminado con fines en la mejora del rendimiento atlético]]></article-title>
<source><![CDATA[Revista Medica Sinergia]]></source>
<year>2020</year>
<volume>5</volume>
<numero>7</numero>
<issue>7</issue>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Implicaciones andrológicas del abuso de esteroides androgénicos anabolizantes]]></article-title>
<source><![CDATA[Rev Int Androl]]></source>
<year>2011</year>
<volume>9</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>160-9</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[AlShareef]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Gokarakonda]]></surname>
<given-names><![CDATA[SB]]></given-names>
</name>
<name>
<surname><![CDATA[Marwaha]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Anabolic Steroid Use Disorder]]></source>
<year>2022</year>
<publisher-loc><![CDATA[StatPearls. Treasure Island (FL) ]]></publisher-loc>
<publisher-name><![CDATA[StatPearls Publishing]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Garcia-Cortes]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Robles-Diaz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Stephens]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Drug induced liver injury an update]]></article-title>
<source><![CDATA[Arch Toxicol]]></source>
<year>2020</year>
<volume>94</volume>
<page-range>3381</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vuppalanchi]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Liangpunsakul]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Chalasani]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Etiology of new-onset jaundice how often is it caused by idiosyncratic drug-induced liver injury in the United States?. Am]]></article-title>
<source><![CDATA[J Gastroenterol]]></source>
<year>2007</year>
<volume>102</volume>
<page-range>558</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lagos-Ortiz]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Espinoza-Flores]]></surname>
<given-names><![CDATA[ST]]></given-names>
</name>
<name>
<surname><![CDATA[Barriga-Arriagada]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
<name>
<surname><![CDATA[Cifuentes-Villena]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Sobarzo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Morales Ojeda]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Caracterización y riesgos respecto al uso ilegal de esteroides anabólicos androgénicos en deportistas]]></article-title>
<source><![CDATA[Revista Observatorio Del Deporte]]></source>
<year>2022</year>
<volume>8</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>11-21</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pontet]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Calleri]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hepatotoxicidad por esteroides anabólicos androgénicos, reporte de 2 casos en Uruguay]]></article-title>
<source><![CDATA[Anfamed]]></source>
<year>2018</year>
<volume>5</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>116-22</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Danan]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Benichou]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Causality assessment of adverse reactions to drugs--I A novel method based on the conclusions of international consensus meetings: application to druginduced liver injuries]]></article-title>
<source><![CDATA[J Clin Epidemiol]]></source>
<year>1993</year>
<volume>46</volume>
<page-range>1323-30</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chalasani]]></surname>
<given-names><![CDATA[NP]]></given-names>
</name>
<name>
<surname><![CDATA[Maddur]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Russo]]></surname>
<given-names><![CDATA[MW]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[ACG Clinical Guideline Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury]]></article-title>
<source><![CDATA[Am J Gastroenterol]]></source>
<year>2021</year>
<volume>116</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>878-98</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
